These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 18262818)

  • 21. Cardiac ryanodine receptor function and regulation in heart disease.
    Lehnart SE; Wehrens XH; Kushnir A; Marks AR
    Ann N Y Acad Sci; 2004 May; 1015():144-59. PubMed ID: 15201156
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Composite polymorphisms in the ryanodine receptor 2 gene associated with arrhythmogenic right ventricular cardiomyopathy.
    Milting H; Lukas N; Klauke B; Körfer R; Perrot A; Osterziel KJ; Vogt J; Peters S; Thieleczek R; Varsányi M
    Cardiovasc Res; 2006 Aug; 71(3):496-505. PubMed ID: 16769042
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Postmortem molecular screening for mutations in ryanodine receptor type 1 (RYR1) gene in psychiatric patients suspected of having died of neuroleptic malignant syndrome.
    Sato T; Nishio H; Iwata M; Kentotsuboi ; Tamura A; Miyazaki T; Suzuki K
    Forensic Sci Int; 2010 Jan; 194(1-3):77-9. PubMed ID: 19931341
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Catecholaminergic polymorphic ventricular tachycardia: recent mechanistic insights.
    Kontula K; Laitinen PJ; Lehtonen A; Toivonen L; Viitasalo M; Swan H
    Cardiovasc Res; 2005 Aug; 67(3):379-87. PubMed ID: 15913575
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A novel mutation in FKBP12.6 binding region of the human cardiac ryanodine receptor gene (R2401H) in a Japanese patient with catecholaminergic polymorphic ventricular tachycardia.
    Aizawa Y; Ueda K; Komura S; Washizuka T; Chinushi M; Inagaki N; Matsumoto Y; Hayashi T; Takahashi M; Nakano N; Yasunami M; Kimura A; Hiraoka M; Aizawa Y
    Int J Cardiol; 2005 Mar; 99(2):343-5. PubMed ID: 15749201
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Genetic analysis of sudden unexplained death: a multidisciplinary approach.
    Kauferstein S; Kiehne N; Jenewein T; Biel S; Kopp M; König R; Erkapic D; Rothschild M; Neumann T
    Forensic Sci Int; 2013 Jun; 229(1-3):122-7. PubMed ID: 23683917
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Calcium channel antagonism reduces exercise-induced ventricular arrhythmias in catecholaminergic polymorphic ventricular tachycardia patients with RyR2 mutations.
    Swan H; Laitinen P; Kontula K; Toivonen L
    J Cardiovasc Electrophysiol; 2005 Feb; 16(2):162-6. PubMed ID: 15720454
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Ryanodine receptors and ventricular arrhythmias: emerging trends in mutations, mechanisms and therapies.
    George CH; Jundi H; Thomas NL; Fry DL; Lai FA
    J Mol Cell Cardiol; 2007 Jan; 42(1):34-50. PubMed ID: 17081562
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Genotypic heterogeneity and phenotypic mimicry among unrelated patients referred for catecholaminergic polymorphic ventricular tachycardia genetic testing.
    Tester DJ; Arya P; Will M; Haglund CM; Farley AL; Makielski JC; Ackerman MJ
    Heart Rhythm; 2006 Jul; 3(7):800-5. PubMed ID: 16818210
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Role of ryanodine receptor mutations in cardiac pathology: more questions than answers?
    Thomas NL; George CH; Lai FA
    Biochem Soc Trans; 2006 Nov; 34(Pt 5):913-8. PubMed ID: 17052226
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Ryanodine receptor mutations associated with stress-induced ventricular tachycardia mediate increased calcium release in stimulated cardiomyocytes.
    George CH; Higgs GV; Lai FA
    Circ Res; 2003 Sep; 93(6):531-40. PubMed ID: 12919952
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Mechanisms of abnormal calcium homeostasis in mutations responsible for catecholaminergic polymorphic ventricular tachycardia.
    Iyer V; Hajjar RJ; Armoundas AA
    Circ Res; 2007 Feb; 100(2):e22-31. PubMed ID: 17234962
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Exon 3 deletion of RYR2 encoding cardiac ryanodine receptor is associated with left ventricular non-compaction.
    Ohno S; Omura M; Kawamura M; Kimura H; Itoh H; Makiyama T; Ushinohama H; Makita N; Horie M
    Europace; 2014 Nov; 16(11):1646-54. PubMed ID: 24394973
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Catecholinergic ventricular tachycardia in children].
    Denjoy I; Postma A; Lupoglazoff JM; Vaksman G; Kamblock J; Leenhardt A; Wilde AA; Guicheney P
    Arch Mal Coeur Vaiss; 2005 May; 98(5):506-12. PubMed ID: 15966600
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Endoplasmic reticulum Ca2+ measurements reveal that the cardiac ryanodine receptor mutations linked to cardiac arrhythmia and sudden death alter the threshold for store-overload-induced Ca2+ release.
    Jones PP; Jiang D; Bolstad J; Hunt DJ; Zhang L; Demaurex N; Chen SR
    Biochem J; 2008 May; 412(1):171-8. PubMed ID: 18092949
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Central core disease is due to RYR1 mutations in more than 90% of patients.
    Wu S; Ibarra MC; Malicdan MC; Murayama K; Ichihara Y; Kikuchi H; Nonaka I; Noguchi S; Hayashi YK; Nishino I
    Brain; 2006 Jun; 129(Pt 6):1470-80. PubMed ID: 16621918
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Unusual clinical presentation in a family with catecholaminergic polymorphic ventricular tachycardia due to a G14876A ryanodine receptor gene mutation.
    Allouis M; Probst V; Jaafar P; Schott JJ; Le Marec H
    Am J Cardiol; 2005 Mar; 95(5):700-2. PubMed ID: 15721128
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cardiac channel molecular autopsy: insights from 173 consecutive cases of autopsy-negative sudden unexplained death referred for postmortem genetic testing.
    Tester DJ; Medeiros-Domingo A; Will ML; Haglund CM; Ackerman MJ
    Mayo Clin Proc; 2012 Jun; 87(6):524-39. PubMed ID: 22677073
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Targeted next generation sequencing application in cardiac channelopathies: Analysis of a cohort of autopsy-negative sudden unexplained deaths.
    Farrugia A; Keyser C; Hollard C; Raul JS; Muller J; Ludes B
    Forensic Sci Int; 2015 Sep; 254():5-11. PubMed ID: 26164358
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A case of catecholaminergic polymorphic ventricular tachycardia caused by two calsequestrin 2 mutations.
    de la Fuente S; Van Langen IM; Postma AV; Bikker H; Meijer A
    Pacing Clin Electrophysiol; 2008 Jul; 31(7):916-9. PubMed ID: 18684293
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.